Cargando…
Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations
High grade gliomas are identified as malignant central nervous tumors that spread rapidly and have a universally poor prognosis. Historically high grade gliomas in the pediatric population have been treated similarly to adult high grade gliomas. For the first time, the most recent classification of...
Autores principales: | Aggarwal, Payal, Luo, Wen, Pehlivan, Katherine C., Hoang, Hai, Rajappa, Prajwal, Cripe, Timothy P., Cassady, Kevin A., Lee, Dean A., Cairo, Mitchell S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722734/ https://www.ncbi.nlm.nih.gov/pubmed/36483545 http://dx.doi.org/10.3389/fimmu.2022.1038096 |
Ejemplares similares
-
Immunotherapeutic Challenges for Pediatric Cancers
por: Hutzen, Brian, et al.
Publicado: (2019) -
Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I)
por: Giotta Lucifero, Alice, et al.
Publicado: (2021) -
Immunotherapies for pediatric cancer: current landscape and future perspectives
por: Hutzen, Brian, et al.
Publicado: (2019) -
Experiences and Expectations for Glioma Immunotherapeutic Approaches
por: Yamanaka, Ryuya, et al.
Publicado: (2014) -
Current Immunotherapeutic Approaches for Malignant Gliomas
por: Han, Myung-Hoon, et al.
Publicado: (2022)